ArticleFrontiers in oncology2024

Decreasing the steroid rapidly may help to improve the clinical outcomes of patients with intestinal steroid-refractory acute graft-versus-host disease receiving basiliximab treatment.

Cong Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.